Europe's most important psychiatry conference, the 27th European Congress of Neuropsychopharmacology (ECNP) will take place in Berlin from 18 to 21 October, 2014.
Neuropsychopharmacology includes many fields which attract significant press attention, such as depression, addiction, Alzheimer's disease, ADHD, etc. Up to 7000 delegates are expected to attend the Berlin congress. The 2014 congress will have a particularly interesting programme, including sessions on:
- Personalised treatment of major depression
- New European pharma research initiatives
- Neuropeptides, obesity and addiction
- Neurobiology of ADHD across the lifespan
Journalists are welcome to attend the conference, and can register at: http://www.
Journalists who cannot attend can still receive advance press releases, by contacting email@example.com
The congress website is: http://www.
The ECNP is Europe largest and most important psychiatric organisation. The ECNP is committed to ensuring that advances in the understanding of brain function and human behaviour are translated into better treatments and enhanced public health. Website: http://www.
For more information about the congress, or for general information on the ECNP and its activities, please contact the ECNP Press Officer, Tom Parkhill:
tel: +39 349 238 8191